Search by Drug Name or NDC
NDC 80725-0250-01 Humatin 250 mg/1 Details
Humatin 250 mg/1
Humatin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Waylis Therapeutics LLC. The primary component is PAROMOMYCIN SULFATE.
Product Information
NDC | 80725-0250 |
---|---|
Product ID | 80725-250_218563ce-a4f4-490b-99fe-eabc713bbdba |
Associated GPIs | 07000055100110 |
GCN Sequence Number | 009585 |
GCN Sequence Number Description | paromomycin sulfate CAPSULE 250 MG ORAL |
HIC3 | W4C |
HIC3 Description | AMEBICIDES |
GCN | 42970 |
HICL Sequence Number | 004155 |
HICL Sequence Number Description | PAROMOMYCIN SULFATE |
Brand/Generic | Brand |
Proprietary Name | Humatin |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | PAROMOMYCIN SULFATE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/1 |
Substance Name | PAROMOMYCIN SULFATE |
Labeler Name | Waylis Therapeutics LLC |
Pharmaceutical Class | Antiprotozoal [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA065173 |
Listing Certified Through | 2024-12-31 |
Package
NDC 80725-0250-01 (80725025001)
NDC Package Code | 80725-250-01 |
---|---|
Billing NDC | 80725025001 |
Package | 100 CAPSULE in 1 BOTTLE (80725-250-01) |
Marketing Start Date | 2021-04-08 |
NDC Exclude Flag | N |
Pricing Information | N/A |